My go-to blend Consistent quality and always easy to order
BPC-157 has been shown to reduce inflammation and promote the healing of the digestive tract, making it a potential candidate for treating these debilitating conditions
Some older studies have evaluated NAD+ at high doses (1-2g daily) for conditions such as chronic schizophrenia, but no improvement was noted in these studies.3 This may be because NAD+ is expected to have poor oral bioavailability.12 For this reason, when trying to boost NAD+ levels using an oral route, precursors such as nicotinamide or nicotinamide mononucleotide are typically used instead of NAD+
We run a brief health check before the first injection, including a blood pressure reading
These investigations remain limited to mechanistic and molecular analysis , without drawing conclusions related to clinical outcomes
The FDA has issued warning letters to vendors distributing injectable BPC-157 as an unapproved research chemical without verified quality controls